Biology & Medicine News and Discussions

weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Miraculous' mosquito hack cuts dengue by 77%
https://www.bbc.com/news/health-57417219
By James Gallagher
Dengue fever cases have been cut by 77% in a "groundbreaking" trial that manipulates the mosquitoes that spread it, say scientists.

They used mosquitoes infected with "miraculous" bacteria that reduce the insect's ability to spread dengue.

The trial took place in Yogyakarta city, Indonesia, and is being expanded in the hope of eradicating the virus.

The World Mosquito Programme team says it could be a solution to a virus that has gone around the world.

Few people had heard of dengue 50 years ago, but it has been a relentless slow-burning pandemic and cases have increased dramatically.

In 1970, only nine countries had faced severe dengue outbreaks, now there are up to 400 million infections a year.

Dengue is commonly known as "break-bone fever" because it causes severe pain in muscles and bones and explosive outbreaks can overwhelm hospitals.
User avatar
Yuli Ban
Posts: 5194
Joined: Sun May 16, 2021 4:44 pm

Re: Biology & Medicine News and Discussions

Post by Yuli Ban »

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
Up until last year, vaccines had not changed very much, at least in concept, for more than two centuries. Most have been modeled on the discovery made in 1796 by the English doctor Edward Jenner, who noticed that many milkmaids were immune to smallpox. They had all been infected by a form of pox that afflicts cows but is relatively harmless to humans, and Jenner surmised that the cowpox had given them immunity to smallpox. So he took some pus from a cowpox blister, rubbed it into scratches he made in the arm of his gardener’s 8-year-old son and then (this was in the days before bioethics panels) exposed the kid to smallpox. He didn’t become ill.

Before then, inoculations were done by giving patients a small dose of the actual smallpox virus, hoping that they would get a mild case and then be immune. Jenner’s great advance was to use a related but relatively harmless virus. Ever since, vaccinations have been based on the idea of exposing a patient to a safe facsimile of a dangerous virus or other germ. This is intended to kick the person’s adaptive immune system into gear. When it works, the body produces antibodies that will, sometimes for many years, fend off any infection if the real germ attacks.

One approach is to inject a safely weakened version of the virus. These can be good teachers, because they look very much like the real thing. The body responds by making antibodies for fighting them, and the immunity can last a lifetime. Albert Sabin used this approach for the oral polio vaccine in the 1950s, and that’s the way we now fend off measles, mumps, rubella and chicken pox.

Throughout human history, we have been subjected to wave after wave of viral and bacterial plagues. One of the earliest known was the Babylon flu epidemic around 1200 B.C. The plague of Athens in 429 B.C. killed close to 100,000 people, the Antonine plague in the 2nd century killed 5 million, the plague of Justinian in the 6th century killed 50 million, and the Black Death of the 14th century took almost 200 million lives, close to half of Europe’s population.

The COVID-19 pandemic that killed more than 1.8 million people in 2020 will not be the final plague. However, thanks to the new RNA technology, our defenses against most future plagues are likely to be immensely faster and more effective. As new viruses come along, or as the current coronavirus mutates, researchers can quickly recode a vaccine’s mRNA to target the new threats. “It was a bad day for viruses,” Moderna’s chair Afeyan says about the Sunday when he got the first word of his company’s clinical trial results. “There was a sudden shift in the evolutionary balance between what human technology can do and what viruses can do. We may never have a pandemic again.”
So long as mRNA vaccines don't have major side effects, as Joe pointed out. They may be the stopgap between the way things were and the Future™ (i.e. hard nanotech), the first big fruit of the biotech revolution.
And remember my friend, future events such as these will affect you in the future
User avatar
Yuli Ban
Posts: 5194
Joined: Sun May 16, 2021 4:44 pm

Re: Biology & Medicine News and Discussions

Post by Yuli Ban »

How mRNA Technology Could Change the World
Synthetic mRNA, the ingenious technology behind the Pfizer-BioNTech and Moderna vaccines, might seem like a sudden breakthrough, or a new discovery. One year ago, almost nobody in the world knew what an mRNA vaccine was, for the good reason that no country in the world had ever approved one. Months later, the same technology powered the two fastest vaccine trials in the history of science.

Like so many breakthroughs, this apparent overnight success was many decades in the making. More than 40 years had passed between the 1970s, when a Hungarian scientist pioneered early mRNA research, and the day the first authorized mRNA vaccine was administered in the United States, on December 14, 2020. In the interim, the idea’s long road to viability nearly destroyed several careers and almost bankrupted several companies.

The dream of mRNA persevered in part because its core principle was tantalizingly simple, even beautiful: The world’s most powerful drug factory might be inside all of us.
That's part of what makes mRNA tech so effective and ubiquitously useful.
And remember my friend, future events such as these will affect you in the future
User avatar
Yuli Ban
Posts: 5194
Joined: Sun May 16, 2021 4:44 pm

Re: Biology & Medicine News and Discussions

Post by Yuli Ban »



Already!
And remember my friend, future events such as these will affect you in the future
weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

New discovery shows human cells can write RNA sequences into DNA

by Thomas Jefferson University
https://phys.org/news/2021-06-discovery ... ences.html
Cells contain machinery that duplicates DNA into a new set that goes into a newly formed cell. That same class of machines, called polymerases, also build RNA messages, which are like notes copied from the central DNA repository of recipes, so they can be read more efficiently into proteins. But polymerases were thought to only work in one direction DNA into DNA or RNA. This prevents RNA messages from being rewritten back into the master recipe book of genomic DNA. Now, Thomas Jefferson University researchers provide the first evidence that RNA segments can be written back into DNA, which potentially challenges the central dogma in biology and could have wide implications affecting many fields of biology.

"This work opens the door to many other studies that will help us understand the significance of having a mechanism for converting RNA messages into DNA in our own cells," says Richard Pomerantz, Ph.D., associate professor of biochemistry and molecular biology at Thomas Jefferson University. "The reality that a human polymerase can do this with high efficiency, raises many questions." For example, this finding suggests that RNA messages can be used as templates for repairing or re-writing genomic DNA.
Maximus
Posts: 69
Joined: Wed May 19, 2021 2:06 am

Re: Biology & Medicine News and Discussions

Post by Maximus »

weatheriscool wrote: Fri Jun 11, 2021 6:26 pm New discovery shows human cells can write RNA sequences into DNA
Fascinating discovery.

However, to address the potential elephant in the room, no, this isn't proof that mRNA vaccines can become part of your genome. DNA is stored in the nucleus, while mRNA is inserted into the cellular cytoplasm. The mRNA in the vaccine doesn't have the necessary components to be transported into the nucleus (random mRNAs can't just enter the nucleus), so it just sits in the cytoplasm and gets translated into protein or degraded.
weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

A touchless technology for early detection of eye diseases

by University of Waterloo
https://medicalxpress.com/news/2021-06- ... eases.html
A non-contact laser imaging system could help doctors diagnose and treat eye diseases that cause blindness much earlier than is now possible.

The new technology, developed by engineering researchers at the University of Waterloo, is designed to detect telltale signs of major blinding diseases in retinal blood and tissue that typically go unseen until it is too late.

With current testing methods, diseases such as age-related macular degeneration, diabetic retinopathy and glaucoma—which have no symptoms in their early stages—are usually diagnosed only after vision is irreversibly affected.

"We're optimistic that our technology, by providing functional details of the eye such as oxygen saturation and oxygen metabolism, may be able to play a critical role in early diagnosis and management of these blinding diseases," said Parsin Haji Reza, director of the PhotoMedicine Labs at Waterloo.

Patented technology at the core of the new system is known as photoacoustic remote sensing (PARS). It uses multicolored lasers to almost instantly image human tissue without touching it.
weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

A potential new treatment target for Alzheimer's disease
https://medicalxpress.com/news/2021-06- ... sease.html
by Keck School of Medicine of USC
Like amyloid plaque, the genetic variant APOE4 has long been associated with Alzheimer's disease, but still little is known about the role the gene plays in the disease process.

Now, a new study published in Nature Aging not only sheds light on how the gene may instigate a cascade of pathologies that contribute to Alzheimer's disease, but also suggests a new treatment target that might help people who carry the APOE4 gene in early and late stages of the disease. Keck School of Medicine of USC researchers found that APOE4 is associated with the activation of an inflammatory protein that causes a breakdown in the blood-brain barrier which protects the brain.

This research builds on a recent USC study that revealed APOE4 triggers leaks in the blood-brain barrier in humans, which lets toxic substances from the blood stream into the brain, damaging brain cells and disrupting cognitive functions. This process causes memory problems in patients whether or not their brain shows signs of amyloid-β, the sticky plaque peptide considered a hallmark of the disease.
weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Stents inspired by paper-cutting art can deliver drugs to the GI tract
https://medicalxpress.com/news/2021-06- ... gs-gi.html
by Massachusetts Institute of Technology
Inspired by kirigami, the Japanese art of folding and cutting paper to create three-dimensional structures, MIT engineers and their collaborators have designed a new type of stent that could be used to deliver drugs to the gastrointestinal tract, respiratory tract, or other tubular organs in the body.

The stents are coated in a smooth layer of plastic etched with small "needles" that pop up when the tube is stretched, allowing the needles to penetrate tissue and deliver a payload of drug-containing microparticles. Those drugs are then released over an extended period of time after the stent is removed.

This kind of localized drug delivery could make it easier to treat inflammatory diseases affecting the GI tract such as inflammatory bowel disease or eosinophilic esophagitis, says Giovanni Traverso, an MIT assistant professor of mechanical engineering, a gastroenterologist at Brigham and Women's Hospital, and the senior author of the study.
weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Coffee Lovers, Rejoice! Drinking More Coffee Linked With Decreased Heart Failure Risk

https://scitechdaily.com/coffee-lovers- ... lure-risk/
By American Heart Association June 14, 2021

Dietary information from three large, well-known heart disease studies suggests drinking one or more cups of caffeinated coffee may reduce heart failure risk, according to research published today in Circulation: Heart Failure, an American Heart Association journal.

Coronary artery disease, heart failure, and stroke are among the top causes of death from heart disease in the U.S. “While smoking, age and high blood pressure are among the most well-known heart disease risk factors, unidentified risk factors for heart disease remain,” according to David P. Kao, M.D., senior author of the study, assistant professor of cardiology and medical director at the Colorado Center for Personalized Medicine at the University of Colorado School of Medicine in Aurora, Colorado.
weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Philips recalls ventilators and sleep apnea CPAP machines over cancer concerns
Source: CBS NEWS

BY KATE GIBSON
Philips is recalling breathing devices and ventilators due to foam that might degrade and become toxic, possibly causing cancer, the Dutch medical equipment maker said on Monday.

The recall involves specific Philips Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP) and mechanical ventilator devices to address potential health risks related to polyester-based polyurethane sound abatement foam that is in the machines, Philips said in a news release.

Foam used to soften the sound made by the machines can deteriorate and project tiny particles and gases that can irritate airways, cause headaches and possibly be toxic or carry cancer risks, according to the company.

No deaths have been reported in connection with the recalled devices.

Read more: https://www.cbsnews.com/news/philips-cp ... ntilators/
weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Brain cell membranes' lipids may play big role in Alzheimer's progression
https://medicalxpress.com/news/2021-06- ... s-big.html
by American Institute of Physics
Alzheimer's disease is predominant in elderly people, but the way age-related changes to lipid composition affect the regulation of biological processes is still not well understood. Links between lipid imbalance and disease have been established, in which lipid changes increase the formation of amyloid plaques, a hallmark of Alzheimer's disease.

This imbalance inspired researchers from Aarhus University in Denmark to explore the role of lipids comprising the cellular membranes of brain cells.

In Biointerphases, the researchers report on the significant role lipids may play in regulating C99, a protein within the amyloid pathway, and disease progression. Lipids have been mostly overlooked from a therapeutic standpoint, likely because their influence in biological function is not yet fully understood.
weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

New metal-free hydrogel electrodes flex to fit the body's many shapes, avoiding damage to organs

by Lindsay Brownell, Hansjörg Wyss Institute for Biologically Inspired Engineering
https://phys.org/news/2021-06-metal-fre ... -body.html
Arrays of metal electrodes are often used in medical procedures that require monitoring or delivering electrical impulses in the body, such as brain surgery and epilepsy mapping. However, the metal and plastic materials that comprise them are stiff and inflexible while the body's tissues are soft and malleable. This mismatch limits the places in which electrode arrays can be successfully used, and also requires the application of a large amount of electrical current in order to "jump" the gap between an electrode and its target.

Inspired by the unique physical properties of living human tissues, a team of scientists from Harvard's Wyss Institute and John A. Paulson School of Engineering and Applied Sciences (SEAS) has created flexible, metal-free electrode arrays that snugly conform to the body's myriad shapes, from the deep creases of the brain to the fibrous nerves of the heart. This close embrace allows electrical impulses to be recorded and stimulated with lower required voltages, enables their use in hard-to-reach areas of the body, and minimizes the risk of damage to delicate organs.
weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Tiny cannabis capsules could help treat neurological diseases
https://medicalxpress.com/news/2021-06- ... eases.html
by Lucien Wilkinson, Curtin University
A team of researchers led by Curtin University has discovered a new way to improve the absorption rate of medicinal cannabis when taken orally, which could potentially be used to treat neurological disorders such as Alzheimer's disease, multiple sclerosis and traumatic brain injuries in the future.

Published in the journal PLOS ONE and funded by industry partner Zelira Therapeutics, the researchers were able to create tiny capsules containing cannabinoids which, when taken orally, were absorbed by the body faster and penetrated the brain quicker in mice models with neurological diseases, than when it was delivered in liquid form.

Lead researcher, Associate Professor Ryu Takechi from the Curtin Health Innovation Research Institute (CHIRI) and the School of Population Health at Curtin University, said there has been a growing interest in the use of cannabidiol to treat various neurological diseases, but there are limitations due its poor absorption and sensitivity to light and stomach acid when consumed orally.
User avatar
Yuli Ban
Posts: 5194
Joined: Sun May 16, 2021 4:44 pm

Re: Biology & Medicine News and Discussions

Post by Yuli Ban »

mRNA vaccine yields full protection against malaria in mice
Scientists from the Walter Reed Army Institute of Research and Naval Medical Research Center partnered with researchers at the University of Pennsylvania and Acuitas Therapeutics to develop a novel vaccine based on mRNA technology that protects against malaria in animal models, publishing their findings in npj Vaccines.

In 2019, there were an estimated 229 million cases of malaria and 409,000 deaths globally, creating an extraordinary cost in terms of human morbidity, mortality, economic burden, and regional social stability. Worldwide, Plasmodium falciparum is the parasite species which causes the vast majority of deaths. Those at highest risk of severe disease include pregnant women, children and malaria naïve travelers. Malaria countermeasures development has historically been a priority research area for the Department of Defense as the disease remains a top threat to U.S. military forces deployed to endemic regions.

A safe, effective malaria vaccine has long been an elusive target for scientists. The most advanced malaria vaccine is RTS,S, a first-generation product developed in partnership with WRAIR. RTS,S is based on the circumsporozoite protein of P. falciparum, the most dangerous and widespread species of malaria parasite. While RTS,S is an impactful countermeasure in the fight against malaria, field studies have revealed limited sterile efficacy and duration of protection. The limitations associated with RTS,S and other first-generation malaria vaccines have led scientists to evaluate new platforms and second-generation approaches for malaria vaccines.
And remember my friend, future events such as these will affect you in the future
User avatar
Ken_J
Posts: 249
Joined: Sun May 16, 2021 5:25 pm

Re: Biology & Medicine News and Discussions

Post by Ken_J »

weatheriscool wrote: Tue Jun 15, 2021 7:54 pm Brain cell membranes' lipids may play big role in Alzheimer's progression
https://medicalxpress.com/news/2021-06- ... s-big.html
by American Institute of Physics
Alzheimer's disease is predominant in elderly people, but the way age-related changes to lipid composition affect the regulation of biological processes is still not well understood. Links between lipid imbalance and disease have been established, in which lipid changes increase the formation of amyloid plaques, a hallmark of Alzheimer's disease.

This imbalance inspired researchers from Aarhus University in Denmark to explore the role of lipids comprising the cellular membranes of brain cells.

In Biointerphases, the researchers report on the significant role lipids may play in regulating C99, a protein within the amyloid pathway, and disease progression. Lipids have been mostly overlooked from a therapeutic standpoint, likely because their influence in biological function is not yet fully understood.
see this is why I'm unsure about indefinite lifespans in humans. It doesn't help to change genes or telomeres if the basic structure of the cell bodies in the brain turn to junk. you'd have clean out and replace most of the brain to solve the problem. And last I checked we are our brains, if we break don, drain out and replace brain we are likely to go with it.
weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Ken_J wrote: Fri Jun 18, 2021 9:59 pm
weatheriscool wrote: Tue Jun 15, 2021 7:54 pm Brain cell membranes' lipids may play big role in Alzheimer's progression
https://medicalxpress.com/news/2021-06- ... s-big.html
by American Institute of Physics
Alzheimer's disease is predominant in elderly people, but the way age-related changes to lipid composition affect the regulation of biological processes is still not well understood. Links between lipid imbalance and disease have been established, in which lipid changes increase the formation of amyloid plaques, a hallmark of Alzheimer's disease.

This imbalance inspired researchers from Aarhus University in Denmark to explore the role of lipids comprising the cellular membranes of brain cells.

In Biointerphases, the researchers report on the significant role lipids may play in regulating C99, a protein within the amyloid pathway, and disease progression. Lipids have been mostly overlooked from a therapeutic standpoint, likely because their influence in biological function is not yet fully understood.
see this is why I'm unsure about indefinite lifespans in humans. It doesn't help to change genes or telomeres if the basic structure of the cell bodies in the brain turn to junk. you'd have clean out and replace most of the brain to solve the problem. And last I checked we are our brains, if we break don, drain out and replace brain we are likely to go with it.
We'll have to develop some kind of computer infrastructure that we could download ourselves into as we're 3-d bioprinting a new brain to then redownload into the new brain that is put back into our skull. We'd have to do this every 80-100 years.

Or we could try to develop a hybrid robotic/human brain that could constantly maintain the upkeep.
weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Implantable brain device relieves pain in early study

by NYU Langone Health
https://medicalxpress.com/news/2021-06- ... -pain.html
A computerized brain implant effectively relieves short-term and chronic pain in rodents, a new study finds.

The experiments, conducted by investigators at NYU Grossman School of Medicine, offer what the researchers call a "blueprint" for the development of brain implants to treat pain syndromes and other brain-based disorders, such as anxiety, depression, and panic attacks.

Publishing June 21 in the journal Nature Biomedical Engineering, the study showed that device-implanted rats withdrew their paws 40 percent more slowly from sudden pain compared with times when their device was turned off.
weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Investigational Alzheimer's drug improves biomarkers of the disease

by Washington University School of Medicine
https://medicalxpress.com/news/2021-06- ... sease.html
An investigational Alzheimer's drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive benefit, in a phase 2/3 clinical trial led by researchers at Washington University School of Medicine in St. Louis through its Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU). These results led the trial leaders to offer the drug, known as gantenerumab, to participants as part of an exploratory open-label extension. The researchers continue to monitor changes in measures of Alzheimer's disease in those participants who are receiving the drug.

The DIAN-TU study (ClinicalTrials.gov Identifier: NCT01760005), published June 21 in Nature Medicine, evaluated the effects of two investigational drugs—gantenerumab, made by Roche and its U.S. affiliate, Genentech, and solanezumab, made by Eli Lilly and Co.—in people with a rare, inherited, early-onset form of Alzheimer's known as dominantly inherited Alzheimer's disease or autosomal dominant Alzheimer's disease. Such people are born with a mutation that causes Alzheimer's, and experience declines in memory and thinking skills starting as early as their 30s or 40s.
weatheriscool
Posts: 24495
Joined: Sun May 16, 2021 6:16 pm
Contact:

Re: Biology & Medicine News and Discussions

Post by weatheriscool »

Derivative of vitamin A enhances the tumor-killing effectiveness of radiotherapy

by Kristin Rattini, University of Chicago Medical Center
https://medicalxpress.com/news/2021-06- ... erapy.html
Radiotherapy is a crucial component in cancer treatment, used in 50 to 60 percent of patients with cancer. It is traditionally used for localized cancers—such as head and neck, cervical, prostate, lung and brain cancers—with varying degrees of success.

A University of Chicago Medicine Comprehensive Cancer Center researcher-led team has discovered that combining radiotherapy with all-trans retinoic acid (ATRA) significantly inhibits the growth of not only locally irradiated tumors, but also distal tumors not treated with radiation. The combination treatment of radiation and ATRA modulates the tumor microenvironment and enhances the effects of radiation on both the local and systemic levels.

"Our group is the first to combine ATRA with radiation to treat solid tumors in animal models," said Ralph Weichselbaum, MD, Daniel K. Ludwig Distinguished Service Professor and chair of Radiation and Cellular Oncology and a senior author of the study, published in the June 11, 2021 issue of Science Immunology.
Post Reply